The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for enhancing healthspan and longevity.
Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...
Pediatric high-grade gliomas , particularly H3K27M diffuse midline gliomas (DMG) , are aggressive malignant brain tumors with a poor prognosis ...
Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.
This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...
Zombie cells are a hot topic in the scientific community, with groundbreaking research being conducted worldwide to find ways ...
Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Recognizing this Achilles' heel, the team tested a combination approach: pairing BRAF inhibitors with the SFK inhibitor ...
Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for 256.8 million euros (nearly $280 million). The company ...
Zydus Life share price: Zydus Life shares rallied as much as 6.80 per cent to hit an intraday high of Rs 947.95 per share on Thursday, March 6, 2025. The uptick in Zydus Life share price came after ...
Stocks to watch: TCS, Wipro, IRFC, Zydus Life, LIC Housing Fin among shares to remain in focus today
IT services company TCS has collaborated with Vantage Towers, Europe’s second-largest telecom tower operator, to introduce a digital service platform. This partnership seeks to optimize service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results